DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Heparin

Heparin

  • Enoxaparin Sodium Solution for Injection, Manufacturer's Standard

    Enoxaparin Sodium Solution for Injection, Manufacturer's Standard

  • Rtpa) for the Treatment of Hepatic Veno-Occlusive Disease (VOD

    Rtpa) for the Treatment of Hepatic Veno-Occlusive Disease (VOD

  • Transition of Anticoagulants 2019

    Transition of Anticoagulants 2019

  • (Dipotassium Salt) and Heparin on the Estimation of Packed Cell Volume

    (Dipotassium Salt) and Heparin on the Estimation of Packed Cell Volume

  • Direct Versus Indirect Thrombin Inhibition in Percutaneous Coronary Intervention

    Direct Versus Indirect Thrombin Inhibition in Percutaneous Coronary Intervention

  • Public Assessment Report

    Public Assessment Report

  • Elective Surgery and Invasive Procedures in Patients Taking

    Elective Surgery and Invasive Procedures in Patients Taking

  • Cleveland Clinic Anticoagulation Management Program (C-Camp)

    Cleveland Clinic Anticoagulation Management Program (C-Camp)

  • Enoxaparin Updated November 2016

    Enoxaparin Updated November 2016

  • Transition of Anticoagulants 2016

    Transition of Anticoagulants 2016

  • The Pharmacodynamic Effect of ELIQUIS Can Be Expected to Persist for at Least 24 Hours After the Last Dose, Ie, for About Two Drug Half Lives

    The Pharmacodynamic Effect of ELIQUIS Can Be Expected to Persist for at Least 24 Hours After the Last Dose, Ie, for About Two Drug Half Lives

  • Expert John L

    Expert John L

  • Clinical Evidence of the Role of Edoxaban in Anticoagulation

    Clinical Evidence of the Role of Edoxaban in Anticoagulation

  • Review of Existing Classification Efforts

    Review of Existing Classification Efforts

  • Heparins and Heparinoids: Occurrence, Structure and Mechanism of Antithrombotic and Hemorrhagic Activities

    Heparins and Heparinoids: Occurrence, Structure and Mechanism of Antithrombotic and Hemorrhagic Activities

  • Protocols for Anticoagulant and Thrombolytic Therapy Mar 2020

    Protocols for Anticoagulant and Thrombolytic Therapy Mar 2020

  • Heparin Injection

    Heparin Injection

  • Clopidogrel Bisulfate Tablets

    Clopidogrel Bisulfate Tablets

Top View
  • Edoxaban Clinical Guide
  • Ethylenediaminetetraacetic Acid (EDTA) – Dependent Pathology Section Pseudothrombocytopenia: a Case Report
  • LIXIANA® (Edoxaban)
  • SAVAYSA (Edoxaban) Tablets for Oral Use Ml/Min (2.1) Initial U.S
  • Heparin Sodium Injection BP
  • Recommended Doses of Anticoagulant/Antithrombotic Therapies for Patients with Atrial Fibrillation
  • Bericht ATC-Code B01: Antithrombotische Mittel
  • Adding Heparin to Aspirin Reduces the Incidence of Myocardial Infarction and Death in Patients with Unstable Angina a Meta-Analysis Allison Oler, MD; Mary A
  • Oral Anticoagulant (Warfarin) Guidelines
  • Unfractionated Heparin, LMWH & Fondaparinux
  • HEPARIN SODIUM, for Intravenous Use USP Units Per 500 Ml) in Single-Dose Freeflex® Bag Initial U.S
  • Introduction to Drug Utilization Research 2003 Introduction to Drug Utilization Research
  • Anti-Platelet and Anti-Coagulant Prescriptions and Breast Cancer Recurrence: a Danish Nationwide Prospective Cohort Study
  • CLEXANE NZ Data Sheet
  • Oral Anticoagulants
  • Some Side Effects of Heparin, Heparinoids, and Their Antagonists
  • Transition of Anticoagulants 2014
  • Oral Direct Thrombin Inhibitors Or Oral Factor Xa Inhibitors for the Treatment of Pulmonary Embolism (Review)


© 2024 Docslib.org    Feedback